Wed, 20/02/2013 - 14:20
Prolog Ventures, a life science venture capital firm, has named John Steuart as a managing director.
He will join managing directors Brian Clevinger, Greg Johnson and Ilya Nykin, who co-founded Prolog in 2000.
Steuart (pictured) has more than 25 years of experience managing healthcare and technology companies and venture capital funds. He began his investing career at the pioneering venture capital firm Alafi Capital, where for a time he worked closely alongside Clevinger. The two later also collaborated on the leadership team of Megan Health, a spinout of Washington University in St. Louis. Steuart went on to serve as the CFO at two venture-backed public companies before returning to venture capital investing as a co-founder and managing director of Claremont Creek Ventures. His practice at Claremont Creek focused on investing in early stage healthcare companies.
"I am thrilled to be on the same team with John again," says Clevinger. "His investment experience and deal flow networks fit perfectly with Prolog's core areas of focus. All of us here at Prolog are convinced that John's presence will boost our ability to build successful life science ventures."
Steuart serves on the advisory boards for the Lester Center of Entrepreneurship and the Center for Entrepreneurship and Technology at UC Berkeley.
"Nothing is more important in the venture capital business than being on the right investment team," says Steuart. "I have gotten to know my Prolog colleagues over the course of many years. I worked with them, I reviewed investments with them, I am a limited partner in one of their funds. It is the right team for me: experienced, focused, hard-working, with a distinct strategy and emphasis on adding value. I am excited to help the firm build its investment practice into an enduring franchise."
Fri 24/03/2017 - 09:07
Thu 23/03/2017 - 14:41
Thu 23/03/2017 - 08:11
Wed 22/03/2017 - 10:09
Fri, 24/Mar/2017 - 14:04
Fri, 24/Mar/2017 - 14:00
Fri, 24/Mar/2017 - 13:55
Fri, 24/Mar/2017 - 13:50
Fri, 24/Mar/2017 - 13:43
Fri, 24/Mar/2017 - 13:26